Approvals/NMPA/Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (III)

Approved

化学药品

Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (III)

北京福元医药股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 1z321J8feS4
Approval Number: 国药准字H20233541
Generic Name: 沙格列汀二甲双胍缓释片(Ⅲ)
Generic Name En: Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (III)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含沙格列汀2.5mg与盐酸二甲双胍1000mg
Reg Date: 2023-05-12
Company Name: 北京福元医药股份有限公司
Company Address: 北京市通州区通州工业开发区广源东街8号
Production Company Name: 北京福元医药股份有限公司
Production Company Address: 北京市通州区通州工业开发区广源东街8号
Company Detail Path: /organization/bei-jing-fu-yuan-yi-yao-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/bei-jing-fu-yuan-yi-yao-gu-fen-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

May 12, 2023

Approval ID

1z321J8feS4

Type

化学药品